The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo
Open accessAbstract
There are no FDA-approved antivirals for any coronavirus, including SARS-CoV-2. Numerous drugs are already approved for human use that may have antiviral activity and therefore could potentially be rapidly repurposed as antivirals. Here, we present data assessing the antiviral activity of 20 FDA-approved drugs against SARS-CoV-2 that also inhibit SARS-CoV and MERS-CoV in vitro . We found that 17 of these inhibit SARS-CoV-2, suggesting that they may have pan-anti-coronaviral activity. We directly followed up seven of these and found that they all inhibit infectious-SARS-CoV-2 production. Moreover, we evaluated chloroquine and chlorpromazine in vivo using mouse-adapted SARS-CoV. We found that neither drug inhibited viral replication in the lungs, but both protected against clinical disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Drug repurposing: progress, challenges and recommendations
Pushpakom, S., Iorio, F., Eyers, P. A., Escott, K. J., Hopper, S., Wells, A., Doig, A., Guilliams, T., Latimer, J., McNamee, C., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.168 · Cited by 4,718
Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Geleris, J., Sun, Y., Platt, J., Zucker, J., Baldwin, M., Hripcsak, G., Labella, A., Manson, D. K., Kubin, C., Barr, R. G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2012410 · Cited by 1,625
Effectiveness of Antimalarial Drugs
Baird, J. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043207 · Cited by 375
Research works printed but not linked: 28
- 10.1056/NEJMoa2001017 · DOI · Paper page
- 10.1021/acsinfecdis.5b00089 · DOI
- 10.1016/j.tim.2018.04.004 · DOI · Paper page
- 10.1371/journal.pone.0060579 · DOI · Paper page
- 10.1128/AAC.03036-14 · DOI · Paper page
- 10.1021/acsinfecdis.5b00030 · DOI · Paper page
- 10.1038/nm.4184 · DOI · Paper page
- 10.1128/JVI.01429-16 · DOI · Paper page
- 10.1099/jgv.0.001047 · DOI
- 10.1371/journal.ppat.0030005 · DOI · Paper page
- 10.1093/ofid/ofaa130 · DOI · Paper page
- 10.1083/jcb.123.5.1107 · DOI · Paper page
- 10.1038/s41586-020-2012-7 · DOI · Paper page
- 10.1073/pnas.79.1.175 · DOI · Paper page
- 10.1093/jac/dkv018 · DOI · Paper page
- 10.1007/s10787-015-0239-y · DOI · Paper page
- 10.1128/JVI.00127-09 · DOI · Paper page
- 10.1371/journal.ppat.1000756 · DOI · Paper page
- 10.1007/s00281-017-0629-x · DOI · Paper page
- 10.1038/s41422-020-0282-0 · DOI · Paper page
- 10.1016/j.antiviral.2019.104541 · DOI · Paper page
- 10.1126/scitranslmed.aal3653 · DOI · Paper page
- 10.1056/NEJMoa2016638 · DOI · Paper page
- 10.1056/NEJMoa2019014 · DOI · Paper page
- 10.1002/9780471729259.mc15e02s37 · DOI
- 10.1128/JVI.05957-11 · DOI
- 10.1093/infdis/jiy345 · doi:10.1093/infdis/jiy345
- 10.1128/JVI.03398-14 · doi:10.1128/jvi.03398-14
Cited by
SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis
Bayati, A., Kumar, R., Francis, V., & McPherson, P. S. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100306 · Cited by 499
Million, M., Lagier, J.-C., Gautret, P., Colson, P., Fournier, P.-E., Amrane, S., Hocquart, M., Mailhe, M., Esteves-Vieira, V., Doudier, B., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101738 · Cited by 469
Si, L., Bai, H., Rodas, M., Cao, W., Oh, C. Y., Jiang, A., Moller, R., Hoagland, D., Oishi, K., Horiuchi, S., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00718-9 · Cited by 440
“This human Organ Chip model also successfully predicted the inability of chloroquine, hydroxychloroquine, and arbidol to work in animals 4 and human patients 1,2,55 , in contrast with what was reported in cell lines 42,56,57 .”
Self-citationArtemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants
Nair, M. S., Huang, Y., Fidock, D. A., Polyak, S. J., Wagoner, J., Towler, M. J., & Weathers, P. J. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114016 · Cited by 122
Barh, D., Tiwari, S., Weener, M. E., Azevedo, V., Góes-Neto, A., Gromiha, M. M., & Ghosh, P. (2020) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.104051 · Cited by 90
Metadata
- Authors
- Weston, S., Coleman, C. M., Haupt, R., Logue, J., Matthews, K., Li, Y., Reyes, H. M., Weiss, S. R., & Frieman, M. B.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2020-10-14
- Volume
- 94
- Issue
- 21
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W3049552342
- Cited by
- 219
- References
- 6
- FWCI
- 5.95
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Funders
- Emergent Biosolutions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo. https://app.cochat.ai/papers/10.1128/jvi.01218-20
- The paper
- Weston, S., Coleman, C. M., Haupt, R., Logue, J., Matthews, K., Li, Y., Reyes, H. M., Weiss, S. R., & Frieman, M. B. (2020). Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo. Journal of Virology. https://doi.org/10.1128/jvi.01218-20
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.